Abbott Laboratories (ABT) Revenue & Revenue Breakdown

Overview ForecastOwnership Financials Chart Transcripts

Abbott Laboratories Revenue Highlights

Latest Revenue (Y)

$40.11B

Latest Revenue (Q)

$10.63B

Main Segment (Y)

Medical Devices

Main Geography (Y)

UNITED STATES

Abbott Laboratories Revenue by Period

Abbott Laboratories Revenue by Year

Date	Revenue	Change
2023-12-31	$40.11B	-8.12%
2022-12-31	$43.65B	1.34%
2021-12-31	$43.08B	24.47%
2020-12-31	$34.61B	8.48%
2019-12-31	$31.90B	4.34%
2018-12-31	$30.58B	11.64%
2017-12-31	$27.39B	31.35%
2016-12-31	$20.85B	2.20%
2015-12-31	$20.41B	0.78%
2014-12-31	$20.25B	-7.33%
2013-12-31	$21.85B	-45.21%
2012-12-31	$39.87B	2.63%
2011-12-31	$38.85B	10.48%
2010-12-31	$35.17B	14.31%
2009-12-31	$30.77B	4.19%
2008-12-31	$29.53B	13.94%
2007-12-31	$25.91B	15.30%
2006-12-31	$22.48B	0.62%
2005-12-31	$22.34B	13.51%
2004-12-31	$19.68B	-0.00%
2003-12-31	$19.68B	11.29%
2002-12-31	$17.68B	8.59%
2001-12-31	$16.29B	18.47%
2000-12-31	$13.75B	4.31%
1999-12-31	$13.18B	5.61%
1998-12-31	$12.48B	5.00%
1997-12-31	$11.88B	7.90%
1996-12-31	$11.01B	10.00%
1995-12-31	$10.01B	9.35%
1994-12-31	$9.16B	8.90%
1993-12-31	$8.41B	-

Abbott Laboratories generated $40.11B in revenue during NA 2023, up -8.12% compared to the previous quarter, and up 131.17% compared to the same period a year ago.

Abbott Laboratories Revenue by Quarter

Date	Revenue	Change
2024-09-30	$10.63B	2.49%
2024-06-30	$10.38B	4.14%
2024-03-31	$9.96B	-2.70%
2023-12-31	$10.24B	0.97%
2023-09-30	$10.14B	1.65%
2023-06-30	$9.98B	2.37%
2023-03-31	$9.75B	-3.41%
2022-12-31	$10.09B	-3.06%
2022-09-30	$10.41B	-7.52%
2022-06-30	$11.26B	-5.36%
2022-03-31	$11.89B	3.72%
2021-12-31	$11.47B	4.94%
2021-09-30	$10.93B	6.90%
2021-06-30	$10.22B	-2.23%
2021-03-31	$10.46B	-2.29%
2020-12-31	$10.70B	20.87%
2020-09-30	$8.85B	20.81%
2020-06-30	$7.33B	-5.15%
2020-03-31	$7.73B	-7.07%
2019-12-31	$8.31B	2.95%
2019-09-30	$8.08B	1.22%
2019-06-30	$7.98B	5.89%
2019-03-31	$7.54B	-2.96%
2018-12-31	$7.76B	1.42%
2018-09-30	$7.66B	-1.43%
2018-06-30	$7.77B	5.10%
2018-03-31	$7.39B	-2.62%
2017-12-31	$7.59B	11.13%
2017-09-30	$6.83B	2.89%
2017-06-30	$6.64B	4.77%
2017-03-31	$6.33B	18.79%
2016-12-31	$5.33B	0.58%
2016-09-30	$5.30B	-0.58%
2016-06-30	$5.33B	9.17%
2016-03-31	$4.88B	-5.84%
2015-12-31	$5.19B	0.74%
2015-09-30	$5.15B	-0.39%
2015-06-30	$5.17B	5.57%
2015-03-31	$4.90B	-7.43%
2014-12-31	$5.29B	3.64%
2014-09-30	$5.10B	-8.05%
2014-06-30	$5.55B	5.85%
2014-03-31	$5.24B	-7.27%
2013-12-31	$5.65B	5.32%
2013-09-30	$5.37B	-1.41%
2013-06-30	$5.45B	1.27%
2013-03-31	$5.38B	-50.37%
2012-12-31	$10.84B	10.88%
2012-09-30	$9.77B	-0.35%
2012-06-30	$9.81B	3.71%
2012-03-31	$9.46B	-8.87%
2011-12-31	$10.38B	5.71%
2011-09-30	$9.82B	2.08%
2011-06-30	$9.62B	6.36%
2011-03-31	$9.04B	-9.30%
2010-12-31	$9.97B	14.91%
2010-09-30	$8.67B	-1.72%
2010-06-30	$8.83B	14.65%
2010-03-31	$7.70B	-12.42%
2009-12-31	$8.79B	13.26%
2009-09-30	$7.76B	3.56%
2009-06-30	$7.49B	11.56%
2009-03-31	$6.72B	-15.50%
2008-12-31	$7.95B	6.04%
2008-09-30	$7.50B	2.51%
2008-06-30	$7.31B	8.11%
2008-03-31	$6.77B	-6.31%
2007-12-31	$7.22B	-

Abbott Laboratories generated $10.63B in revenue during Q3 2024, up 2.49% compared to the previous quarter, and up 106.58% compared to the same period a year ago.

Abbott Laboratories Revenue Breakdown

Abbott Laboratories Revenue Breakdown by Product

Annual Revenue by Product

Product/Service	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Nutritional Products	$8.15B	$7.46B	$8.29B	$7.65B	$7.41B
Established Pharmaceutical Products	$5.07B	$4.91B	$4.72B	$4.30B	$4.49B
Medical Devices	$16.89B	$14.69B	$435.00M	$430.00M	$380.00M
Diagnostic Products	$9.99B	$16.58B	$4.00B	$3.80B	$3.30B

Abbott Laboratories's latest annual revenue breakdown by segment (product or service), as of Dec 23: Medical Devices (42.12%), Diagnostic Products (24.91%), Nutritional Products (20.34%), and Established Pharmaceutical Products (12.63%).

Quarterly Revenue by Product

Product/Service	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19
Medical Devices	$4.75B	$4.73B	$4.45B	$4.44B	$4.25B	$475.00M	$450.00M	$433.00M	$436.00M	$428.00M	$3.75B	$445.00M	$414.00M	$400.00M	$3.26B	$430.00M	$415.00M	$400.00M	-	-
Diagnostic Products	$5.30B	$4.80B	$4.50B	-	$4.20B	$4.20B	$4.10B	$3.90B	$3.90B	$3.80B	$4.47B	$3.90B	$3.90B	$3.80B	$4.34B	$3.60B	$3.50B	$3.40B	$2.06B	$3.20B
Established Pharmaceutical Products	$1.41B	$1.29B	$1.23B	$1.22B	$1.37B	$1.15B	$1.20B	$1.26B	$1.18B	$1.07B	$1.15B	$1.10B	$1.01B	$1.04B	$1.17B	$1.21B	-	-	-	-
Nutritional Products	$2.07B	$2.15B	$2.07B	$2.04B	$2.07B	$1.89B	$2.04B	$2.11B	$2.11B	$2.04B	$1.94B	$1.92B	$1.88B	$1.90B	$1.87B	$1.87B	-	-	-	-
Other Segment	-	-	-	-	-	-	-	-	-	$3.00M	$3.00M	$11.00M	-	-	-	-	-	-	-	-
All Other Segments	-	-	-	-	-	-	-	-	-	-	-	-	$22.00M	$16.00M	$16.00M	$20.00M	$15.00M	$15.00M	$681.00M	-
Cardiovascular And Neuromodulation Products	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$350.00M

Abbott Laboratories's latest quarterly revenue breakdown by segment (product or service), as of Sep 24: Diagnostic Products (39.20%), Medical Devices (35.11%), Nutritional Products (15.28%), and Established Pharmaceutical Products (10.40%).

Abbott Laboratories Revenue Breakdown by Country

Annual Revenue by Country

Country	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
NETHERLANDS	$1.07B	-	-	-	-
JAPAN	$1.51B	$1.93B	-	-	-
INDIA	$1.75B	$1.65B	-	-	-
GERMANY	$2.35B	$2.34B	-	-	-
SWITZERLAND	$1.64B	$1.34B	-	-	-
CHINA	$2.25B	$2.13B	-	-	-
Non-US	$14.08B	$14.84B	-	-	-
UNITED STATES	$15.45B	$18.14B	-	-	-
CANADA	-	$1.28B	-	-	-
All Other Countries	-	$14.84B	$15.52B	-	-
Canada	-	-	$1.39B	-	-
China	-	-	$2.39B	-	-
Germany	-	-	$2.57B	-	-
India	-	-	$1.56B	-	-
Japan	-	-	$1.70B	-	-
Switzerland	-	-	$1.31B	-	-
I	-	-	-	$1.32B	$1.40B
J	-	-	-	$1.39B	$1.44B
N	-	-	-	$1.08B	$975.00M
Other Countries	-	-	-	$12.58B	$11.53B
D	-	-	-	$2.11B	$1.75B
C	-	-	-	$1.14B	$1.07B

Abbott Laboratories's latest annual revenue breakdown by geography, as of Dec 23: UNITED STATES (38.53%), Non-US (35.11%), GERMANY (5.85%), CHINA (5.62%), INDIA (4.36%), SWITZERLAND (4.08%), JAPAN (3.77%), and NETHERLANDS (2.68%).

Quarterly Revenue by Country

Country	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 18
Non-US	$6.43B	$6.44B	$6.12B	-	$6.33B	$6.22B	$5.82B	$5.87B	$6.32B	$6.37B	-
UNITED STATES	$4.20B	$3.93B	$3.85B	$3.95B	$3.82B	$3.76B	$3.93B	$4.22B	$4.09B	$4.89B	-
U	-	-	-	-	-	-	-	-	-	-	$94.00M
Non Us	-	-	-	-	-	-	-	-	-	-	$336.00M

Abbott Laboratories's latest quarterly revenue breakdown by geography, as of Sep 24: Non-US (60.49%), and UNITED STATES (39.51%).

Abbott Laboratories Peer Comparison by Revenue

Ticker	Company	Last Year Revenue	Last Quarter Revenue
JNJ	Johnson & Johnson	$85.15B	$22.47B
ABBV	AbbVie	$54.32B	$14.46B
BMY	Bristol-Myers Squibb Company	$45.01B	$11.89B
ABT	Abbott Laboratories	$40.11B	$10.63B
LLY	Eli Lilly and Company	$34.12B	$11.44B
MDT	Medtronic	$32.36B	$8.40B

ABT Revenue FAQ

What is Abbott Laboratories’s yearly revenue?

Abbott Laboratories's yearly revenue for 2023 was $40.11B, representing a decrease of -8.12% compared to 2022. The company's yearly revenue for 2022 was $43.65B, representing an increase of 1.34% compared to 2021. ABT's yearly revenue for 2021 was $43.08B, representing an increase of 24.47% compared to 2020.

What is Abbott Laboratories’s quarterly revenue?

Abbott Laboratories's quarterly revenue for Q3 2024 was $10.64B, a 2.49% increase from the previous quarter (Q2 2024), and a 4.85% increase year-over-year (Q3 2023). The company's quarterly revenue for Q2 2024 was $10.38B, a 4.14% increase from the previous quarter (Q1 2024), and a 4.00% increase year-over-year (Q2 2023). ABT's quarterly revenue for Q1 2024 was $9.96B, a -2.70% decrease from the previous quarter (Q4 2023), and a 2.23% increase year-over-year (Q1 2023).

What is Abbott Laboratories’s revenue growth rate?

Abbott Laboratories's revenue growth rate for the last 3 years (2021-2023) was -6.89%, and for the last 5 years (2019-2023) was 25.72%.

What are Abbott Laboratories’s revenue streams?

Abbott Laboratories's revenue streams in c 23 are Nutritional Products, Established Pharmaceutical Products, Medical Devices, and Diagnostic Products. Nutritional Products generated $8.15B in revenue, accounting 20.34% of the company's total revenue, up 9.32% year-over-year. Established Pharmaceutical Products generated $5.07B in revenue, accounting 12.63% of the company's total revenue, up 3.14% year-over-year. Medical Devices generated $16.89B in revenue, accounting 42.12% of the company's total revenue, up 14.98% year-over-year. Diagnostic Products generated $9.99B in revenue, accounting 24.91% of the company's total revenue, down -39.77% year-over-year.

What is Abbott Laboratories’s main source of revenue?

For the fiscal year ending Dec 23, the largest source of revenue of Abbott Laboratories was Medical Devices. This segment made a revenue of $16.89B, representing 42.12% of the company's total revenue.